Rate of TP53 mutations in HPV-positive (HPV+) recurrent/metastatic head and neck cancer (RMHNC) patients.

被引:0
|
作者
Thach, Dzung
Ahmad, Moin
Penta, Adrienne L.
Sulkowski, Gisela N.
Kallakury, Bhaskar
Chahine, Joeffrey J.
Niederhuber, John E.
Iyer, Ramaswamy K.
Deeken, John F.
机构
[1] Inova Translat Med Inst, Falls Church, VA USA
[2] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[3] Inova Comprehens Canc & Res Inst, Mclean, VA USA
关键词
D O I
10.1200/jco.2015.33.15_suppl.e17094
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e17094
引用
收藏
页数:1
相关论文
共 50 条
  • [31] TP53 gene expression in HPV-positive oral tongue SCC and its correlation with nodal metastasis
    Seraj, Jalal Mehdizadeh
    Yazdani, Nasrin
    Ashtiani, Zahra Ousati
    Seraj, Siamak Mehdizadeh
    Hasheminasab, Sayed-Mohammad
    Memar, Bahram
    Mirashrafi, Fatemeh
    Borghei, Hasti
    Yazdani, Javad
    Mostaan, Leila Vazifeh
    PATHOLOGY RESEARCH AND PRACTICE, 2011, 207 (12) : 758 - 761
  • [32] Is radiation dose reduction the right answer for HPV-positive head and neck cancer?
    Kimple, Randall J.
    Harari, Paul M.
    ORAL ONCOLOGY, 2014, 50 (06) : 560 - 564
  • [33] DEK promotes HPV-positive and -negative head and neck cancer cell proliferation
    Adams, A. K.
    Hallenbeck, G. E.
    Casper, K. A.
    Patil, Y. J.
    Wilson, K. M.
    Kimple, R. J.
    Lambert, P. F.
    Witte, D. P.
    Xiao, W.
    Gillison, M. L.
    Wikenheiser-Brokamp, K. A.
    Wise-Draper, T. M.
    Wells, S. I.
    ONCOGENE, 2015, 34 (07) : 868 - 877
  • [34] DEK promotes HPV-positive and -negative head and neck cancer cell proliferation
    A K Adams
    G E Hallenbeck
    K A Casper
    Y J Patil
    K M Wilson
    R J Kimple
    P F Lambert
    D P Witte
    W Xiao
    M L Gillison
    K A Wikenheiser-Brokamp
    T M Wise-Draper
    S I Wells
    Oncogene, 2015, 34 : 868 - 877
  • [35] Treatment De-Intensification for Patients With HPV-Positive Head and Neck Cancers
    Gillison, Maura L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (5.5): : 596 - 599
  • [36] Establishment of HPV-positive and HPV-negative head and neck cancer tumorgrafts directly from patient biopsies
    Torres, Alexandra D.
    Kimple, Randall J.
    Yang, Robert Z.
    Soriano, Benjamin
    Armstrong, Eric A.
    Harari, Paul M.
    Lambert, Paul F.
    CANCER RESEARCH, 2012, 72
  • [37] SUCCESSFUL GENERATION OF HPV-SPECIFIC T CELL LINES FOR T CELL THERAPY OF PATIENTS WITH HPV-POSITIVE HEAD AND NECK CANCER
    Basso, S.
    Guido, I.
    Secondino, S.
    Quartuccio, G.
    Gurrado, A.
    Paglino, C.
    Pellerano, A.
    Acquafredda, G.
    Rubert, L.
    Maccario, R.
    Zecca, M.
    Comoli, P.
    Pedrazzoli, P.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S206 - S207
  • [38] Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer
    Guo, Theresa
    Qualliotine, Jesse R.
    Ha, Patrick K.
    Califano, Joseph A.
    Kim, Young
    Saunders, John R.
    Blanco, Ray G.
    D'Souza, Gypsyamber
    Zhang, Zhe
    Chung, Christine H.
    Kiess, Ana
    Gourin, Christine G.
    Koch, Wayne
    Richmon, Jeremy D.
    Agrawal, Nishant
    Eisele, David W.
    Fakhry, Carole
    CANCER, 2015, 121 (12) : 1977 - 1984
  • [39] mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer
    Coppock Joseph D.
    Lee John H.
    世界耳鼻咽喉头颈外科杂志英文版, 2016, (02) : 76 - 83
  • [40] Cisplatin and radiation therapy induces an immunologic clearance of HPV-positive head and neck cancer
    PW Nowicki
    WC Spanos
    DW Lee
    ME Anderson
    AJ Hoover
    JH Lee
    Infectious Agents and Cancer, 4 (Suppl 2)